Funding of drug treatment of multiple sclerosis should not be delayed.
Paty
D W
DW
D000276:Adjuvants, Immunologic / Q000191:economics* / Q000627:therapeutic use; D002202:Capital Financing; D002986:Clinical Trials as Topic; D003657:Decision Making; D006801:Humans; D016899:Interferon-beta / Q000191:economics* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta